Trial intelligence / Profile preview

Naltrexone vs Acamprosate in Alcohol Dependence

NCT00120601Phase 4Unknown

Sponsor
University of Sydney
Start
Mar 2003
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in alcohol dependence comparing Naltrexone with Acamprosate (2 arms). Primary endpoints: Time to relapse, Time to lapse and 3 more. Status: unknown.

02

Drugs

naltrexoneacamprosate
03

Conditions

alcohol dependence

Beyond the preview

Go deeper on NCT00120601.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00120601.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call